Rockefeller University Press

Table 1

Characteristics of Subjects

Normal subjects

n = 9 (5 M, 4 F)

Age 39.4 ± 5.8 yr^*

Total number of hepatitis C patients

n = 26 (17 M, 9 F)

Chronic hepatitis (18)

Chronic hepatitis with cirrhosis (8)

Hepatitis C patients not on IFN-α treatment (never treated or blood sampled before started on IFN-α treatment)

n = 18 (14 M, 4 F)

Age 43.8 ± 10.5 yr

Hepatitis C patients on IFN-α treatment

n = 15 (10 M, 5 F)

Age 40.7 ± 10.5 yr

3 to 10 million units IFN-α three times/wk

1–40 wk of treatment

26.4 ± 12.0 h from last injection until blood draw

Serum IFN-α levels

Normal subjects:

13.8 ± 0.2 pg/ml

Hepatitis C:

14.5 ± 0.8 pg/ml

Hepatitis C on IFN-α:

34.0 ± 13.9 pg/ml^‡

Mean ± SD.

P <0.04. M, male; F, female.